Aminologics Co.,Ltd. (KOSDAQ:074430)
1,210.00
-8.00 (-0.66%)
At close: Jun 10, 2026
Aminologics Revenue
Aminologics had revenue of 5.38B KRW in the quarter ending March 31, 2026, with 13.87% growth. This brings the company's revenue in the last twelve months to 22.68B, up 36.76% year-over-year. In the year 2025, Aminologics had annual revenue of 22.02B with 31.15% growth.
Revenue (ttm)
22.68B
Revenue Growth
+36.76%
P/S Ratio
4.70
Revenue / Employee
566.90M
Employees
40
Market Cap
106.62B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 22.02B | 5.23B | 31.15% |
| Dec 31, 2024 | 16.79B | -4.10B | -19.61% |
| Dec 31, 2023 | 20.89B | -6.45B | -23.60% |
| Dec 31, 2022 | 27.34B | 4.49B | 19.64% |
| Dec 31, 2021 | 22.85B | 5.20B | 29.45% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UIL Co., Ltd. | 402.18B |
| DongKoo Bio & Pharma | 242.08B |
| ActRO | 240.57B |
| MSC Co., Ltd. | 197.62B |
| Amosense | 118.82B |
| Systeel Tech | 103.15B |
| NBR Motion | 62.51B |
| JI-Tech | 56.32B |